The prospective study of relation between 5-HIAA/substance P and nausea/vomiting in patients who receiving moderately emetogenic chemotherapy
Not Applicable
- Conditions
- esophagogastrointestinal cancer
- Registration Number
- JPRN-UMIN000021072
- Lead Sponsor
- Hokkaido University Hospital Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Not provided
Exclusion Criteria
using antiemetics within 48 hours except for prevention from chemotherapy-induced nausea and vomiting. cannot eat by mouth. using more than 10mg/m2 corticosteroids within 72 hours except for prevention from chemotherapy-induced nausea and vomiting. clarified brain metastasis. nausea and vomiting within 24 hours before receiving chemotherapy. pregnant or lactating women. with uncontrolable infection or diabetes mellitus. allergy for 5HT receptor blocker or aprepitant. can not cooperate with the blood collection
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method